Status:
WITHDRAWN
Failed Endometrial Ablation Treatment With Implantable Progesterone (FEAT) Study
Lead Sponsor:
Saskatchewan Health Authority - Regina Area
Collaborating Sponsors:
University of Saskatchewan
Conditions:
Abnormal Uterine Bleeding
Dysmenorrhea
Eligibility:
FEMALE
18+ years
Phase:
PHASE2
Brief Summary
The objective of this study is to assess the efficacy of an implantable etonogestrel device in reducing hysterectomy rate in patients with a failed endometrial ablation.
Detailed Description
The researchers aim to determine whether use of etonogestrel implant in patients with failed endometrial ablation significantly decreases hysterectomy rate. Changes in pelvic pain and vaginal bleeding...
Eligibility Criteria
Inclusion
- Previous endometrial ablation
- Pelvic pain and/or vaginal bleeding seeking treatment
Exclusion
- Previous or current VTE
- Liver tumour, benign or malignant, or active liver disease
- Undiagnosed abnormal genital bleeding
- Known or suspected breast cancer
- Uncontrolled hypertension
- Allergy to component of etonogestrel implant
- Lack of patient consent
Key Trial Info
Start Date :
July 1 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
April 30 2024
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT05227456
Start Date
July 1 2022
End Date
April 30 2024
Last Update
November 25 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Saskatchewan Health Authority
Regina, Saskatchewan, Canada